Cleared Traditional

K210477 - AtriCure Isolator Encompass Ablation System, GLIDEPATH Magnetic GUIDE (FDA 510(k) Clearance)

Jul 2021
Decision
157d
Days
Class 2
Risk

K210477 is an FDA 510(k) clearance for the AtriCure Isolator Encompass Ablation System, GLIDEPATH Magnetic GUIDE. This device is classified as a Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue (Class II - Special Controls, product code OCL).

Submitted by AtriCure, Inc. (Mason, US). The FDA issued a Cleared decision on July 26, 2021, 157 days after receiving the submission on February 19, 2021.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 878.4400. Surgical Device For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue.

Submission Details

510(k) Number K210477 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 19, 2021
Decision Date July 26, 2021
Days to Decision 157 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code OCL — Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4400
Definition Surgical Device For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue

Similar Devices — OCL Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue

Isolator® Synergy™ EnCompass Clamp and Guide system (OLH, OSH, GPM100)
K252056 · AtriCure, Inc. · Jul 2025
Isolator Synergy EnCapture Ablation System (EMH)
K234151 · AtriCure, Inc. · Aug 2024
Isolator® Linear Pen (MLP1)
K221358 · AtriCure, Inc. · Dec 2022
Cardioblate Gemini-s 49260 Surgical Ablation Device
K223508 · Medtronic, Inc. · Dec 2022
AtriCure Isolator® Synergy™ Surgical Ablation System
K211311 · AtriCure, Inc. · May 2021